Merck is investing $250 million in a Swiss biotechnology facility

Merck is investing $250 million in a Swiss biotechnology facility

In Corsier-sur-Vevey, Switzerland the Merck Biotech Center for Biotech Development and manufacturing in clinical studies announced an investment of US$ 250 million in a new facility. Driven by the growth of the R+D pipeline for healthcare business, this investment will…

cancer Market

Immunity From Cancer Cure- A Miracle Drug

A new discovery has been found regarding cancer treatment and effective results have been made from those drugs. It has an increasing chances of getting patients treated very soon, the sufferings of the patients will lessen down and it will…

Gasoline Direct Injection (GDI) System Market
Inflators Market
Locker Locks Market
Magnetic Ink Character Recognition (MICR) Printer Market
PV Junction Box Market
Resistive Random Access Memory Market